S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

AMLX Amylyx Pharmaceuticals Inc

3.87

0.26 (7.20%)

Mar 07 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Amylyx Pharmaceuticals Charts.

Amylyx Pharmaceuticals (NASDAQ:AMLX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Amylyx Pharmaceuticals Charts.

Amylyx Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 5 March 2025 (4 days ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 4 March 2025 (5 days ago) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Tuesday 4 March 2025 (5 days ago) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Tuesday 4 March 2025 (5 days ago) • Edgar (US Regulatory)

Form POSASR - Post-effective Amendment to an automatic shelf registration statement
Tuesday 4 March 2025 (5 days ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 March 2025 (5 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 26 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
Tuesday 25 February 2025 (2 weeks ago) • Business Wire

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
Monday 24 February 2025 (2 weeks ago) • Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 14 February 2025 (3 weeks ago) • Edgar (US Regulatory)

More Amylyx Pharmaceuticals Inc News Articles

Asia Broadband (PK)

Kraig Biocraft Laborator... (QB)

Voip Pal Com (QB)

Good Vibrations Shoes (PK)

NioCorp Developments

Elite Pharmaceuticals (QB)

Lightwave Logic

Bioelectronics (PK)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions